PT - JOURNAL ARTICLE AU - Christina M. Newman AU - Dawn M. Dudley AU - Roger W. Wiseman AU - Matthew T. McLaughlin AU - Julie A. Karl AU - Miranda R. Stauss AU - Andrea M. Weiler AU - Mason I. Bliss AU - Mitchell D. Ramuta AU - Cecilia G. Shortreed AU - Amelia K. Haj AU - Anna S. Heffron AU - Matthew R. Reynolds AU - Katrina N. Fauser AU - Corrie B. Burmeister AU - Kristi L. Hall AU - Thomas C. Friedrich AU - Shelby L. O’Connor AU - David H. O’Connor TI - Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy AID - 10.1101/2020.07.28.20164038 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.28.20164038 4099 - http://medrxiv.org/content/early/2020/08/05/2020.07.28.20164038.short 4100 - http://medrxiv.org/content/early/2020/08/05/2020.07.28.20164038.full AB - SARS-CoV-2 control in the United States is hampered by limited testing. We evaluated a simple, outdoor, mobile RT-LAMP assay workflow where self-collected saliva is tested for SARS-CoV-2 RNA. 494 volunteers were tested over 16 days. Testing results were 99.8% concordant with qRT-PCR, with all but two people testing SARS-CoV-2-negative.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was made possible by financial support through NIH Rapid Acceleration of Diagnostics (contract number pending). Additional funding was provided by both Wisconsin National Primate Research Center (WNPRC) and from Wisconsin Alumni Research Foundation COVID-19 Challenge.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was performed under approved UW-Madison Health Sciences IRB Protocol #2020-0855.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and protocols are available at https://openresearch.labkey.com/wiki/Coven/page.view?name=field-testing